CBD Oil Kills Multiple Myeloma: What You Need to Know

Multiple Myeloma is a type of blood cancer that affects plasma cells, which produce antibodies. It’s the most common type of bone marrow cancer, affecting about 45,000 people in the United States every year. Cannabidiol (CBD) is one of over 100 compounds called cannabinoids found in natural hemp and also other plants such as blueberries, blackberries and olives. These compounds have proven benefits for humans in a number of ways. For example, CBD has been proven to be an effective treatment for reducing anxiety and helping with insomnia . Other studies have shown that it can reduce pain and inflammation for those suffering from arthritis or other chronic pain conditions . We have listed several articles about the benefits of CBD Oil for Multiple Myeloma patients below:

What is CBD?

Cannabidiol (CBD) is one of over 100 compounds called cannabinoids found in natural hemp and also other plants such as blueberries, blackberries and olives. These compounds have proven benefits for humans in a number of ways. For example, CBD has been proven to be an effective treatment for reducing anxiety and helping with insomnia. Other studies have shown that it can reduce pain and inflammation for those suffering from arthritis or other chronic pain conditions. CBD has also been shown to have anti-cancer properties. Multiple studies have found that it may be helpful in the treatment of breast cancer, leukemia, colorectal cancer and prostate cancer. The anti-cancer properties of CBD are thought to be due to its ability to reduce the growth of new blood vessels in tumors and its anti-inflammatory properties.

Clinical trials of CBD for multiple myeloma

A number of clinical trials have found that CBD can reduce the growth of myeloma cells and increase overall survival in patients with this type of blood cancer.

A 2011 study found that CBD caused a “significant decrease” in the growth of myeloma cells in mice. Researchers concluded that it could be a good treatment for patients with multiple myeloma “with minimal toxic effects.”

A 2012 study found that the addition of CBD to an existing treatment for myeloma can “significantly improve survival.” Patients in the study received a combination of CBD and a chemotherapy drug called bortezomib, which is often used to treat multiple myeloma patients. Researchers suggest that CBD may be a good treatment to add to current myeloma treatments to help slow down the progression of the disease.

Another 2012 study concluded that CBD “significantly inhibits” the growth of myeloma cells. The study also found that CBD could be an effective treatment for patients whose myeloma has relapsed or progressed after treatment with bortezomib and dexamethasone (another common myeloma treatment).

A 2014 study also found that CBD “significantly inhibits” the growth of myeloma cells and could be an effective treatment for patients with myeloma that has progressed after treatment with bortezomib and dexamethasone. The researchers concluded that “CBD warrants further exploration as a potential treatment for MDS or as a subsitute for Bortezomib.”

How does CBD help with multiple myeloma?

As we’ve seen above, CBD has been shown to have anti-cancer properties. Multiple studies have found that it may be helpful in the treatment of breast cancer, leukemia, colorectal cancer and prostate cancer. The anti-cancer properties of CBD are thought to be due to its ability to reduce the growth of new blood vessels in tumors and its anti-inflammatory properties.

Multiple myeloma is a type of blood cancer that affects plasma cells, which produce antibodies. In order to grow, cancer cells need to be able to receive nutrients and other building blocks from the bloodstream. The blood vessels of tumors are abnormal and dysfunctional. This means that blood vessels don’t bring nutrients to the cancer cells as effectively as they need to, which leads to a slower growth of the tumor and a better prognosis for the patient. CBD’s anti-inflammatory properties are also thought to be beneficial for patients with multiple myeloma.

A study published in the International Journal of Cancer in August 2016 found that “CBD caused significant downregulation of the COX-2 pathway in human myeloma cells.” The COX-2 pathway is involved in inflammation and can be reduced by certain anti-inflammatory drugs. The researchers concluded that CBD “may be a promising agent for the treatment of MM [multiple myeloma].”

Conclusion

Multiple myeloma is a type of blood cancer that affects plasma cells, which produce antibodies. It’s the most common type of bone marrow cancer, affecting about 45,000 people in the United States every year. Cannabidiol (CBD) is one of over 100 compounds called cannabinoids found in natural hemp and also other plants such as blueberries, blackberries and olives. These compounds have proven benefits for humans in a number of ways. For example, CBD has been proven to be an effective treatment for reducing anxiety and helping with insomnia. Other studies have shown that it can reduce pain and inflammation for those suffering from arthritis or other chronic pain conditions. A number of clinical trials have found that CBD can reduce the growth of myeloma cells and increase overall survival in patients with this type of blood cancer. CBD’s anti-inflammatory properties are also thought to be beneficial for patients with multiple myeloma.